Clinical trials identified intravitreal vascular endothelial growth factor inhibitors (anti-VEGF
agents) have the potential to stabilise or even improve visual acuity outcomes in …

Purpose: To report the efficacy and safety of intravitreal ranibizumab for neovascular age-
related macular degeneration (nAMD) in real-world practice. Methods: Metaanalysis of∼ …

Age-related macular degeneration (AMD) is a degenerative disease of the human retina
affecting individuals over the age of 55 years. This heterogeneous condition arises from a …

Purpose Single center, noninterventional cohort study to assess 10-year visual and
anatomical outcomes following initiation of treatment with antivascular endothelial growth …

The aim of this systematic literature review is twofold,(1) detail the impact of retinal
biomarkers identifiable via optical coherence tomography (OCT) on disease progression …

Purpose Real-world visual outcomes of anti–vascular endothelial growth factor (anti-VEGF)
therapy for neovascular age-related macular degeneration (nAMD) have been reported in …

This report by a group of UK retina specialists and health professionals considers best
practice recommendations for the management of sight-threatening neovascular age-related …

The real-world performance of a home telemonitoring strategy (ForeseeHome AMD
Monitoring System®, Notal Vision, Inc., Manassas VA, USA) was evaluated and compared to …

Background While randomized controlled trials (RCTs) are based on strict
inclusion/exclusion criteria, non-interventional studies (NISs) might provide additional …

Purpose To report trends in real-world outcomes of anti-vascular endothelial growth factor
(anti-VEGF) therapy for neovascular age-related macular degeneration (nAMD) in the …